Colin Hislop
2012 - Anthera Pharmaceuticals
In 2012, Colin Hislop earned a total compensation of $539.6K as Chief Medical Officer at Anthera Pharmaceuticals, a 31% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $24,441 |
|---|---|
| Option Awards | $107,384 |
| Salary | $347,500 |
| Stock Awards | $60,314 |
| Total | $539,639 |
Hislop received $347.5K in salary, accounting for 64% of the total pay in 2012.
Hislop also received $24.4K in non-equity incentive plan, $107.4K in option awards and $60.3K in stock awards.
Rankings
In 2012, Colin Hislop's compensation ranked 8,526th out of 11,487 executives tracked by ExecPay. In other words, Hislop earned more than 25.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,526 out of 11,487 | 26th |
Division Manufacturing | 3,096 out of 4,253 | 27th |
Major group Chemicals And Allied Products | 830 out of 1,203 | 31st |
Industry group Drugs | 605 out of 925 | 35th |
Industry Pharmaceutical Preparations | 471 out of 700 | 33rd |
Source: SEC filing on April 9, 2015.
Hislop's colleagues
We found five more compensation records of executives who worked with Colin Hislop at Anthera Pharmaceuticals in 2012.
2012
Paul Truex
Anthera Pharmaceuticals
Chief Executive Officer
2012
Debra Odink
Anthera Pharmaceuticals
Chief Technology Officer
2012
Christopher Lowe
Anthera Pharmaceuticals
Chief Financial Officer
2012
Georgina Kilfoil
Anthera Pharmaceuticals
Senior Vice President, Product Development
2012
May Liu
Anthera Pharmaceuticals